Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Setipiprant did not significantly improve hair growth in men with hair loss.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Dutasteride may protect the brain in early Parkinson's disease.

Finasteride reduces movement issues in Parkinson's disease rats.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

PDRN helps repair tissue and improve wound healing with a high safety profile.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

New compounds may help treat prostate issues without affecting androgen receptors.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Dipotassium glycyrrhizinate helps wounds heal faster, especially in the early stages.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.